Get notified of page updates

Featured Research Search Results

PRINTER FRIENDLY PAGE

Search

Virtual
Virtual
PRINTER FRIENDLY PAGE
54 Results Found

Featured research search results for

Treatment

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone or Darolutamide (TALENT)

Clinicaltrials.gov identifier:
NCT06844383

Treatment
Study for metastatic castration-resistant prostate cancer with an HRR mutation

Phase 2

ERADICATE: Hormone and Targeted Therapy for HR+/HER2-Low Advanced Breast Cancer

Clinicaltrials.gov identifier:
NCT07198724

Treatment
Study of hormone and targeted therapy for advanced breast cancer

Phase 1/2

Using a Computer Model to Identify Treatment Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

Clinicaltrials.gov identifier:
NCT07067138

Treatment
Treatment study for people with metastatic breast cancer

Treating Advanced MSI-High or dMMR Cancers Using the Targeted Therapy MOMA-341 Given Alone or In Combination with Standard Therapies

Clinicaltrials.gov identifier:
NCT06974110

Treatment
Treatment study for people with advanced or metastatic cancers

Phase 1

A New Drug, DT2216, Combined With Paclitaxel for Recurrent Platinum-Resistant Ovarian Cancer

Clinicaltrials.gov identifier:
NCT06964009

Treatment
Treatment study for people with recurrent platinum-resistant ovarian cancer

Phase 1

Comparing Treatment with Sacituzumab Govitecan and Bevacizumab to Chemotherapy and Bevacizumab for Recurrent Ovarian Cancer After PARP Inhibitor Maintenance Therapy

Clinicaltrials.gov identifier:
NCT07504588

Treatment
Study for platinum-sensitive ovarian cancer that has progressed after PARP inhibitor

Phase 2

Study of Dostarlimab Immunotherapy in People with Mismatch Repair-Deficient Endometrial Cancer Who Wish to Preserve Fertility

Clinicaltrials.gov identifier:
NCT04165772

Treatment
Treatment study for people with MSI-H or dMMR early-stage endometrial cancer

Phase 2

A Study to Learn About the Study Medicine Called PF-07248144 in Combination with Fulvestrant in People with HR-positive, HER2-negative Advanced or Metastatic Breast Cancer who Progressed After a Prior Line of Treatment

Clinicaltrials.gov identifier:
NCT07062965

Treatment
Study for adults with advanced/metastatic HR-positive, HER2-negative breast cancer who have progressed from prior treatment

Phase 3

Comparing Shorter vs. Standard Radiation for High-Risk Prostate Cancer (High Five)

Clinicaltrials.gov identifier:
NCT05946213

Treatment
Treatment study for high-risk prostate cancer

Phase 3

Testing the Drug CX-5461 for Treating Metastatic Solid Tumors

Clinicaltrials.gov identifier:
NCT06606990

Treatment
Phase 1 study for treatment of advanced solid tumors

Phase 1

Using the Drug Daraxonrasib in Surgically Removed Pancreatic Cancer (RASolute 304)

Clinicaltrials.gov identifier:
NCT07252232

Treatment
Study for pancreatic cancer treatment after surgery and chemotherapy

Phase 3

Comparing Daraxonrasib With or Without Chemotherapy to Chemotherapy Alone for First-Line Treatment of Metastatic Pancreatic Cancer (Rasolute 303)

Clinicaltrials.gov identifier:
NCT07491445

Treatment
Study for First-Line Treatment of Metastatic Pancreatic Cancer

Phase 3

Testing a Targeted Therapy ETX-19477 to Treat Advanced Solid Tumors in People with a BRCA2 Mutation (ERADIC8)

Clinicaltrials.gov identifier:
NCT06395519

Treatment
Treatment study for people with advanced breast, colorectal, endometrial, ovarian or pancreatic cancer

Phase 1/2

Study of a New Oral Medication, Daraxonrasib After Surgery to Help Prevent Pancreatic Cancer from Returning

Clinicaltrials.gov identifier:
NCT07252232

Treatment
Phase 3 treatment trial for pancreatic cancer that was removed by surgery

Phase 3

Comparing Two Vaccine Treatments With Immunotherapy for Pancreatic Cancer Before and After Surgery

Clinicaltrials.gov identifier:
NCT06782932

Treatment
Treatment study for newly diagnosed pancreatic cancer that can be removed with surgery and who have not yet received treatment

Phase 1/2

Using a Blood Test to Detect Early Cancer Recurrence After Treatment (ORACLE)

Clinicaltrials.gov identifier:
NCT05059444

Treatment
Post-treatment study to monitor for recurrence